He was a member of Vifor’s Corporate Executive Committee and a member of the Board of Directors of the joint venture with Fresenius Medical Care (Vifor Fresenius Medical Care Renal Pharma). Befor Vifor, Eklund spent a decade in Boston as Vice President and a member of the Executive Committee at Organogenesis Inc., a Nasdaq-listed world leading company in regenerative medicine and cell therapy. He started his career with various roles in sales, global marketing, business development and general management at Novartis and Sanofi in a number of territories.

Outgoing Santhera CEO Thomas Meier will continue as a Board Member and will chair the newly formed Board of Director’s Scientific Committee.